October 12, 2004; 63 (7) Articles
How effective is BCNU in recurrent glioblastoma in the modern era?
A phase II trial
A. A. Brandes, A. Tosoni, P. Amistà, L. Nicolardi, D. Grosso, F. Berti, M. Ermani
First published October 11, 2004, DOI: https://doi.org/10.1212/01.WNL.0000140495.33615.CA
A. A. Brandes
A. Tosoni
P. Amistà
L. Nicolardi
D. Grosso
F. Berti
How effective is BCNU in recurrent glioblastoma in the modern era?
A phase II trial
A. A. Brandes, A. Tosoni, P. Amistà, L. Nicolardi, D. Grosso, F. Berti, M. Ermani
Neurology Oct 2004, 63 (7) 1281-1284; DOI: 10.1212/01.WNL.0000140495.33615.CA
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 63 no. 7 1281-1284
PubMed:
Print ISSN:
Online ISSN:
History:
- Received March 30, 2004
- Accepted June 2, 2004
- First Published October 11, 2004.
Copyright & Usage:
© 2004
Author Disclosures
- A. A. Brandes, MD,
- A. Tosoni, MD,
- P. Amistà, MD,
- L. Nicolardi, MD,
- D. Grosso, RN,
- F. Berti, MD and
- M. Ermani, MD
- A. A. Brandes, MD,
- A. Tosoni, MD,
- P. Amistà, MD,
- L. Nicolardi, MD,
- D. Grosso, RN,
- F. Berti, MD and
- M. Ermani, MD
- From the Departments of Medical Oncology (Drs. Brandes, Tosoni, and Nicolardi, D. Grosso), Neuroradiology (Dr. P. Amistà), Radiotherapy (Dr. Berti), and Neurological Sciences (Dr. Ermani), Azienda Ospedale-Università, Padova, Italy.
- Address correspondence and reprint requests to Dr. Alba A. Brandes, Department of Medical Oncology, Azienda Ospedale-Università, Ospedale Busonera, Via Gattamelata 64, 35100 Padova, Italy; e-mail: aabrandes{at}unipd.it
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan
Related Articles
- No related articles found.